Phase III KEYNOTE-590 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer


Kato K., Shah M., Enzinger P., Bennouna J., Shen L., Adenis A., ...More

Annals of Oncology, vol.29, 2018 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 29
  • Publication Date: 2018
  • Doi Number: 10.1093/annonc/mdy282.168
  • Journal Name: Annals of Oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Istanbul University-Cerrahpasa Affiliated: No